X0607 3 2026-05-18 0 0001806952 Lyell Immunopharma, Inc. LYEL 0002095697 Innovative Cellular Therapeutics Holdings Ltd true 190 ELGIN AVENUE GEORGE TOWN E9 KY1-9008 CAYMAN ISLANDS true Common Stock 3000000 D Consists of (i) 1,900,000 shares of common stock acquired by the Reporting Person on the Effective Date of the License Agreement, dated November 6, 2025, between the Issuer and the Reporting Person, as partial upfront consideration (the "Upfront Payment"), and (ii) 1,100,000 shares of common stock that the Reporting Person became entitled to receive, and acquired the right to acquire, upon the achievement of a development milestone under the License Agreement on 05/18/2026. The Reporting Person is deemed to have acquired beneficial ownership of such shares on the date its right to receive them became fixed. All shares are held of record by, and registered in the name of, the Reporting Person. Innovative Cellular Therapeutics Holdings Limited By: /s/ Lei Xiao Name: Lei Xiao Title: Chief Executive Officer 2026-06-18